| A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma VW Rusch, K Rosenzweig, E Venkatraman, L Leon, A Raben, L Harrison, ... The Journal of thoracic and cardiovascular surgery 122 (4), 788-795, 2001 | 595 | 2001 |
| Lymph node staging in gastric cancer: is location more important than number?: an analysis of 1,038 patients MS Karpeh, L Leon, D Klimstra, MF Brennan Annals of surgery 232 (3), 362-371, 2000 | 481 | 2000 |
| Identification of prognostic factors in advanced epithelial ovarian carcinoma DS Chi, JB Liao, LF Leon, ES Venkatraman, ML Hensley, D Bhaskaran, ... Gynecologic oncology 82 (3), 532-537, 2001 | 352 | 2001 |
| Factors determining outcome after surgical resection of T3 and T4 lung cancers of the superior sulcus VW Rusch, KR Parekh, L Leon, E Venkatraman, MS Bains, RJ Downey, ... The Journal of thoracic and cardiovascular surgery 119 (6), 1147-1153, 2000 | 186 | 2000 |
| FIR: efficacy, safety, and biomarker analysis of a phase II open-label study of atezolizumab in PD-L1–selected patients with NSCLC DR Spigel, JE Chaft, S Gettinger, BH Chao, L Dirix, P Schmid, LQM Chow, ... Journal of Thoracic Oncology 13 (11), 1733-1742, 2018 | 142 | 2018 |
| Complications associated with intraperitoneal chemotherapy catheters S Makhija, M Leitao, P Sabbatini, N Bellin, L Almadrones, L Leon, ... Gynecologic Oncology 81 (1), 77-81, 2001 | 119 | 2001 |
| Alternative analysis methods for time to event endpoints under nonproportional hazards: a comparative analysis RS Lin, J Lin, S Roychoudhury, KM Anderson, T Hu, B Huang, LF Leon, ... Statistics in Biopharmaceutical Research 12 (2), 187-198, 2020 | 94 | 2020 |
| Chest wall resection for locally recurrent breast cancer: is it worthwhile? RJ Downey, V Rusch, FI Hsu, L Leon, E Venkatraman, D Linehan, ... The Journal of thoracic and cardiovascular surgery 119 (3), 420-428, 2000 | 94 | 2000 |
| Bevacizumab maintenance in patients with advanced non–small-cell lung cancer, clinical patterns, and outcomes in the Eastern Cooperative Oncology Group 4599 Study: results of … A Lopez-Chavez, T Young, S Fages, L Leon, JH Schiller, A Dowlati, ... Journal of Thoracic Oncology 7 (11), 1707-1712, 2012 | 83 | 2012 |
| Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin, a new antifolate LM Krug, KK Ng, MG Kris, VA Miller, W Tong, RT Heelan, L Leon, ... Clinical cancer research 6 (9), 3493-3498, 2000 | 73 | 2000 |
| Safety and effectiveness of bevacizumab-containing treatment for non–small-cell lung cancer: final results of the ARIES observational cohort study TJ Lynch Jr, DR Spigel, J Brahmer, N Fischbach, J Garst, M Jahanzeb, ... Journal of Thoracic Oncology 9 (9), 1332-1339, 2014 | 67 | 2014 |
| Characterization of molecular abnormalities in human fibroblastic neoplasms: a model for genotype-phenotype association in soft tissue tumors A Hoos, JJ Lewis, CR Antonescu, ME Dudas, L Leon, JM Woodruff, ... Cancer research 61 (7), 3171-2175, 2001 | 56 | 2001 |
| Isolating the role of bevacizumab in elderly patients with previously untreated nonsquamous non–small cell lung cancer: secondary analyses of the ECOG 4599 and PointBreak trials CJ Langer, MA Socinski, JD Patel, AB Sandler, JH Schiller, L Leon, ... American journal of clinical oncology 39 (5), 441-447, 2016 | 54 | 2016 |
| Estimation of treatment effects in weighted log-rank tests RS Lin, LF León Contemporary clinical trials communications 8, 147-155, 2017 | 52 | 2017 |
| Phase II study of carboxyamidotriazole in patients with advanced renal cell carcinoma refractory to immunotherapy: E4896, an Eastern Cooperative Oncology Group Study JP Dutcher, L Leon, J Manola, DM Friedland, B Roth, G Wilding Cancer: Interdisciplinary International Journal of the American Cancer …, 2005 | 33 | 2005 |
| Clinical outcomes in elderly patients with advanced non-small cell lung cancer: results from ARIES, a bevacizumab observational cohort study AJ Wozniak, MP Kosty, M Jahanzeb, JR Brahmer, DR Spigel, L Leon, ... Clinical Oncology 27 (4), 187-196, 2015 | 31 | 2015 |
| Targeted therapy for gastrointestinaI (GI) tumors based on molecular profiles: Early results from MyPathway, an open-label phase IIa basket study in patients with advanced … H Hurwitz, JD Hainsworth, C Swanton, EA Perez, C Sweeney, HA Burris, ... Journal of Clinical Oncology 34 (4_suppl), 653-653, 2016 | 30 | 2016 |
| Erlotinib therapy after initial platinum doublet therapy in patients with EGFR wild type non-small cell lung cancer: results of a combined patient-level analysis of the NCIC … RU Osarogiagbon, F Cappuzzo, T Ciuleanu, L Leon, B Klughammer Translational lung cancer research 4 (4), 465, 2015 | 27 | 2015 |
| The costs and efficacy of liposomal doxorubicin in platinum-refractory ovarian cancer in heavily pretreated patients ML Hensley, B Hoppe, L Leon, P Sabbatini, C Aghajanian, D Chi, ... Gynecologic oncology 82 (3), 464-469, 2001 | 25 | 2001 |
| The association of rash severity with overall survival: findings from patients receiving erlotinib for pancreatic cancer in the community setting EJ Stepanski, C Reyes, MS Walker, S Satram-Hoang, L Leon, ... Pancreas 42 (1), 32-36, 2013 | 24 | 2013 |
